FDA official logo
GSRS logo
PFDA official logo

ATEZOLIZUMAB

  • UNII: 52CMI0WC3Y
  • Preferred Substance Name: ATEZOLIZUMAB

  • 1380723-44-3
  • 0INE2SFD9E
  • AN ANTIBODY TO PROGRAMMED DEATH LIGAND 1 FOR CANCER THERAPY
  • ATEZOLIZUMAB [INN]
  • ATEZOLIZUMAB [JAN]
  • ATEZOLIZUMAB [MI]
  • ATEZOLIZUMAB [PURPLE BOOK CDER]
  • ATEZOLIZUMAB [USAN]
  • ATEZOLIZUMAB [WHO-DD]
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD274) (HUMAN MONOCLONAL MPDL3280A HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MPDL3280A .KAPPA.-CHAIN, DIMER
  • MPDL3280A
  • MPDL-3280A
  • RG7446
  • RG-7446
  • TECENTRIQ

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.